The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An evaluation of blood mRNA expression array signatures derived from unsupervised analyses in the identification of prostate cancers with poor outcome.
D. Olmos
No relevant relationships to disclose
J. Clark
No relevant relationships to disclose
D. Brewer
No relevant relationships to disclose
L. Barwell
No relevant relationships to disclose
G. Attard
No relevant relationships to disclose
A. H. Reid
No relevant relationships to disclose
S. K. Sandhu
No relevant relationships to disclose
A. Zivi
No relevant relationships to disclose
D. Bianchini
No relevant relationships to disclose
N. Babu Oomen
No relevant relationships to disclose
E. Thompson
No relevant relationships to disclose
L. R. Molife
No relevant relationships to disclose
S. B. Kaye
No relevant relationships to disclose
C. Parker
No relevant relationships to disclose
C. Cooper
No relevant relationships to disclose
R. J. Jones
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca
J. S. De Bono
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca